Crossmark

The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer

Published Online: 2022-07-13

Published Print: 2022-12

Authors

Sirhan, Zaid

Thyagarajan, Anita

Sahu, Ravi P. https://orcid.org/0000-0003-3857-9073
License Information

Text and Data Mining valid from 2022-07-13

Version of Record valid from 2022-07-13
More Information

Article History

Received: 8 February 2022

Accepted: 6 July 2022

First Online: 13 July 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current